DARE (STOCKS)
Dare Bioscience, Inc. Common Stock
$1.770000
-0.060000 (-3.28%)
Prev close: $1.830000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Sabrina Martucci Johnson
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $25.92M
- Employees
- 23
- P/E (TTM)
- -1.34
- P/B (TTM)
- 9.33
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $1.03M |
| Benefits Costs and Expenses | $14.57M |
| Cost Of Revenue | $295.80K |
| Costs And Expenses | $14.57M |
| Gross Profit | $734.39K |
| Operating Expenses | $14.29M |
| Selling, General, and Administrative Expenses | $8.76M |
| Research and Development | $5.52M |
| Operating Income/Loss | -$13.55M |
| Income/Loss From Continuing Operations After Tax | -$13.54M |
| Income/Loss From Continuing Operations Before Tax | -$13.54M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$13.40M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$13.40M |
| Net Income/Loss Available To Common Stockholders, Basic | -$13.40M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.20 |
| Diluted Earnings Per Share | -$1.20 |
| Basic Average Shares | 11,178,752 |
| Diluted Average Shares | 11,178,752 |
| Assets | $32.47M |
| Current Assets | $27.06M |
| Prepaid Expenses | $2.35M |
| Other Current Assets | $24.71M |
| Noncurrent Assets | $5.41M |
| Fixed Assets | $1.56M |
| Other Non-current Assets | $3.85M |
| Liabilities | $29.63M |
| Current Liabilities | $23.69M |
| Accounts Payable | $1.20M |
| Wages | $10.26K |
| Other Current Liabilities | $22.47M |
| Noncurrent Liabilities | $5.95M |
| Equity | $2.84M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.84M |
| Liabilities And Equity | $32.47M |
| Net Cash Flow From Operating Activities | -$9.89M |
| Net Cash Flow From Operating Activities, Continuing | -$9.90M |
| Net Cash Flow From Investing Activities | -$385.28K |
| Net Cash Flow From Investing Activities, Continuing | -$385.28K |
| Net Cash Flow From Financing Activities | $19.28M |
| Net Cash Flow From Financing Activities, Continuing | $19.28M |
| Exchange Gains/Losses | $7.19K |
| Net Cash Flow | $9.01M |
| Net Cash Flow, Continuing | $8.99M |
| Comprehensive Income/Loss | -$13.39M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$13.39M |
| Other Comprehensive Income/Loss | -$13.39M |